Syeda, M. M., Wiggins, J. M., Corless, B. C., Long, G. V., Flaherty, K. T., Schadendorf, D., . . . Polsky, D. (2021). Clinical validation study of circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib. Lancet Oncol.
Chicago Style CitationSyeda, Mahrukh M., et al. "Clinical Validation Study of Circulating Tumour DNA in Patients With Advanced Melanoma Treated With Dabrafenib or Dabrafenib Plus Trametinib." Lancet Oncol 2021.
Cita MLASyeda, Mahrukh M., et al. "Clinical Validation Study of Circulating Tumour DNA in Patients With Advanced Melanoma Treated With Dabrafenib or Dabrafenib Plus Trametinib." Lancet Oncol 2021.
Atenció: Aquestes cites poden no estar 100% correctes.